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Riboflavin or vitamin B2 is the precursor of the essential coenzymes flavin
mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Despite increased interest
in microbial synthesis of this water-soluble vitamin, the metabolic pathway for riboflavin
biosynthesis has been characterized in just a handful of bacteria. Here, comparative
genome analysis identified the genes involved in the de novo biosynthetic pathway
of riboflavin in certain bifidobacterial species, including the human gut commensal
Bifidobacterium longum subsp. infantis (B. infantis) ATCC 15697. Using comparative
genomics and phylogenomic analysis, we investigated the evolutionary acquisition route
of the riboflavin biosynthesis or rib gene cluster in Bifidobacterium and the distribution
of riboflavin biosynthesis-associated genes across the genus. Using B. infantis ATCC
15697 as model organism for this pathway, we isolated spontaneous riboflavin
overproducers, which had lost transcriptional regulation of the genes required for
riboflavin biosynthesis. Among them, one mutant was shown to allow riboflavin release
into the medium to a concentration of 60.8 ng mL−1. This mutant increased vitamin
B2 concentration in a fecal fermentation system, thus providing promising data for
application of this isolate as a functional food ingredient.
Keywords: probiotic, vitamin B2, gut commensal, vitamin biosynthesis, health benefit
INTRODUCTION
Riboflavin (i.e., vitamin B2) is a precursor of flavin mononucleotide (FMN) and flavin adenine
dinucleotide (FAD), cofactors acting as essential electron carriers in redox reactions of cell
metabolism (LeBlanc et al., 2011). Besides playing an important role in a range of biochemical
reactions, riboflavin serves as a signaling molecule in bacterial quorum sensing and bacterium-
plant interactions, while intermediates of the riboflavin biosynthesis pathway are also involved in
host-microbe signaling (Rajamani et al., 2008; Corbett et al., 2014; Dakora et al., 2015). Only plants,
fungi, and various eubacteria encode the complete enzymatic machinery for de novo riboflavin
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biosynthesis (Bacher et al., 2000; Fischer et al., 2004). Humans
need to regularly obtain this vitamin through their diet as they
are unable to synthesize or store it. For this reason, riboflavin
is an ingredient in various fortified foods and multivitamin
supplements. Absorption of riboflavin occurs in the small and
large intestine through specific carriers (Thakur et al., 2017).
The recommended daily allowance for riboflavin increases with
age, reaching up to 1.1 and 1.3 mg in adult women and men,
respectively, and is the highest (1.6 mg) in lactating mothers
(Institute of Medicine, 1998).
Riboflavin had been produced by chemical means until
commercially competitive microbial processes were developed
to facilitate large-scale production. Biotechnological processes
with various microbial cell factories such as Bacillus subtilis,
Candida flareri, and especially, Ashbya gossypii, represent typical
examples of white biotechnology (Stahmann et al., 2000;
Ledesma-Amaro et al., 2015). In recent years, vitamin production
by lactic acid bacteria (LAB) and bifidobacteria has received
increased attention. These organisms are widely exploited by
the food and pharmaceutical industries as starters for fermented
products and/or as probiotic supplements aiming to improve
human health. Utilization of vitamin-producing bacteria in
food manufacturing has the obvious advantage of achieving
in situ food fortification, which represents a non-artificial and
economically viable strategy (Thakur et al., 2016). Vitamin-
producing probiotic strains that may colonize, at least transiently,
the human intestine, have the advantage of providing the host
with a continuous supply of this micronutrient. Certain members
of the genus Bifidobacterium have previously been proposed
to supply vitamins, but, unlike folate, riboflavin-producing
bifidobacteria have so far not been assessed (Pompei et al.,
2007a,b; D’Aimmo et al., 2012; Sugahara et al., 2015). Notably,
among bifidobacteria the presence of a complete riboflavin
biosynthesis pathway and associated cluster has so far only
been reported in B. longum subsp. infantis (Sela et al., 2008;
Kwak et al., 2016).
Bacteria synthesize FMN and FAD according to the pathway
outlined in Figure 1, starting from one molecule of guanosine-5′-
triphosphate (GTP) and two molecules of ribulose-5-phosphate
(Vitreschak et al., 2002; Fischer et al., 2004). The RibAB,
RibD, RibE and RibH riboflavin biosynthetic enzymes are
encoded by the rib operon, while the genes encoding RibCF
and RibU, the latter a transporter for the uptake of pre-
formed riboflavin, are typically located elsewhere on the
chromosome (Vitreschak et al., 2002; Burgess et al., 2006a;
Thakur et al., 2016). The first step of riboflavin biosynthesis
is catalyzed by the enzyme GTP cyclohydrolase/dihydroxy-2-
butanone-phosphate synthase (RibAB), which is responsible
for the formation of formate and 3,4-dihydroxy-2-butanone
4-phosphate (DHBP) from D-ribulose 5-phosphate and 2,5-
diamino-6-beta-ribosyl-4(3H)-pyrimidinone 5’-phosphate
(DARP) from GTP, which are precursors of the aromatic ring
of riboflavin. A reductase/deaminase (RibD) catalyzes the
subsequent reduction of the ribose side chain in DARP to
produce 5-amino-6-(5-phospho-D-ribitylamino)uracil. The last
two steps of the pathway are then completed by a lumazine
synthase (RibH) and a riboflavin synthase (RibE). The obtained
riboflavin is then converted by phosphorylation into FMN and
FAD by a reaction catalyzed by a riboflavin kinase/FAD synthase
(RibCF; Figures 1A,B). In Firmicutes and in Actinobacteria, de
novo biosynthesis is regulated through a feedback mechanism
involving transcriptional attenuation via an FMN-sensing
mRNA riboswitch (Mironov et al., 2002; Vitreschak et al., 2002).
If present, FMN is bound with high affinity by the 5’-untranslated
region (5’-UTR) of the nascent transcript of the rib operon, which
serves as the FMN-binding aptamer. The binding causes the
transcript to switch to its anti-antiterminator structure, allowing
a termination hairpin to form thereby prematurely ending rib
operon transcription (Kil et al., 1992; Mironov et al., 2002;
Vitreschak et al., 2002).
Roseoflavin is an antibacterial compound and a structural
analog of riboflavin, produced by Streptomyces davawensis (Mack
et al., 1998; Ott et al., 2009). This antimetabolite binds to
the active site of FAD synthetase and flavokinase yielding
inactive complexes of roseoflavin mononucleotide (RoFMN) and
roseoflavin adenine dinucleotide (RoFAD), thereby inhibiting
major cellular reactions. Additionally, RoFMN mimics FMN
in the riboswitch regulation and suppresses de novo vitamin
production (Mack et al., 1998; Ott et al., 2009; Ludwig
et al., 2018). Isolation of spontaneous roseoflavin-resistant
mutants is a reliable method to obtain riboflavin-overproducing
strains of various species, since increased vitamin production
counteracts roseoflavin toxicity by competitive binding to
FAD synthetase (Matsui et al., 1982). This approach, which
does not involve deliberate genetic engineering and may thus
be acceptable for food applications, has generated various
riboflavin-producing mutants that can be exploited to produce
riboflavin-enriched foods employing LAB and propionibacteria
(e.g., Lactococcus lactis, Lactobacillus plantarum, Lactobacillus
fermentum, Propionibacterium freudenreichii; Burgess et al., 2004,
2006b; LeBlanc et al., 2005, 2006; Capozzi et al., 2011; Russo et al.,
2014; Juarez Del Valle et al., 2016; Mohedano et al., 2019; Yepez
et al., 2019; Ge et al., 2020).
The biosynthetic pathway for riboflavin had previously been
predicted for some bifidobacterial strains, such as the type strain
Bifidobacterium longum subsp. infantis ATCC 15697 (hereinafter
referred to as B. infantis ATCC 15697; Kwak et al., 2016).
However, riboflavin-(over)producing strains have never been
described and little is known about biosynthesis and regulation of
this vitamin in bifidobacteria. In the present study, the presence
of the riboflavin and FMN/FAD biosynthetic pathway was
assessed in all annotated Bifidobacterium genomes. Spontaneous
roseoflavin-resistant mutants of B. infantis ATCC 15697 were
obtained and were shown to constitutively produce riboflavin,
which was released in the growth medium. Promising evidence
for or a potential application in the probiotic industry was
obtained in a fecal fermentation system, in which the strain was
shown to increase the overall riboflavin concentration.
MATERIALS AND METHODS
Comparative Bioinformatic Analysis
Protein coding sequences derived from a total of 662
representative strains from 83 bifidobacterial (sub)species
were retrieved from the NCBI Reference Sequence collection
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FIGURE 1 | Flavin adenine dinucleotide (FAD) biosynthesis and corresponding gene loci predicted in the genome of Bifidobacterium longum. (A) General bacterial
pathway of FAD biosynthesis. Stoichiometrically, the formation of riboflavin requires one equivalent of GTP and two equivalents of ribulose 5-phosphate. Reactions
are catalyzed by enzymes: RibAB (1, 5), bifunctional GTP cyclohydrolase II [EC:3.5.4.25]/(3,4-dihydroxy-2-butanone 4-phosphate synthase [EC:4.1.99.12]; RibD (2,
3), bifunctional diaminohydroxyphosphoribosylaminopyrimidine deaminase [EC:3.5.4.26]/5-amino-6-(5-phosphoribosylamino)uracil reductase [EC:1.1.1.193];
unknown enzyme (4), 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase [EC:3.1.3.104]; RibH (6), 6,7-dimethyl-8-ribityllumazine synthase [EC:2.5.1.78]; RibE
(7) riboflavin synthase [EC:2.5.1.9]; RibCF (8, 9), bifunctional riboflavin kinase [EC:2.7.1.26]/FAD synthetase [EC:2.7.7.2]; Based on Bacher et al., 2000; (B) Gene loci
encoding for the riboflavin synthesis enzymes in Bifidobacterium infantis ATCC 15697. Arrow marks the promoter, lollipop marks the FMN riboswitch upstream the
rib cluster and ribU gene.
Refseq1 database and constituted the input for the comparative
analysis. The occurrence and distribution of the riboflavin
biosynthesis genes Blon_386–389 and Blon_2195 across
Bifidobacterium was performed using BLASTP alignments
(Altschul et al., 1990) against a database build from the open
reading frames (ORFs) collection of each bifidobacterial species.
Proteins homologous to any of the riboflavin-associated gene
products from B. infantis across the Bifidobacterium genus were
identified using cut-off values of 40% of similarity across 70%
of protein length and an e-value of < 0.0001 for significance.
The result of the alignments was represented as a heatmap
using the “heatmaply” package implemented in the statistical
1ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/bacteria
software R2 and using a two-way hierarchical clustering with
a color gradient expressing the degree of sequence similarity
across bifidobacterial species, which were also classified by
the origin of isolation. A homologous cluster was defined as
present across bifidobacterial genomes when the four genes
constituting the ribDEABH cluster were found co-located within
the same genomic region with an average similarity above 40%
at protein level.
Prediction of the FMN riboswitch in B. infantis and
Bifidobacterium was performed using Infernal tool v1.1.3
implemented in Bioconda environment3 and the alignment
of the FMN riboswitch was performed using Muscle
2https://www.r-project.org/about.html
3https://github.com/bioconda
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alignment tool v3.8.31 (Edgar, 2004) and visualized using
https://alignmentviewer.org/.
Chemicals and Media
All chemicals were purchased from (Sigma-Aldrich, St. Louis
MO, United States) unless otherwise stated.
Bifidobacteria were routinely cultured anaerobically in
Lactobacilli de Man, Rogosa and Sharpe (MRS) Broth (BD Difco,
Sparks, MD, United States) containing 0.5 g L−1 cysteine HCl.
Riboflavin production in pure Bifidobacterium cultures was
tested in riboflavin-free semi-synthetic medium mSM7. Based
on SM7 medium (Pompei et al., 2007a) with modifications,
mSM7 is composed assembling three sterile solutions: (A)
10 × carbohydrate solution (sterilized by autoclaving at 121◦C
for 20 min); (B) 10 × vitamin solution (pyridoxine, 2 mg
L−1; nicotinic acid, 2 mg L−1; thiamine, 2 mg L−1; calcium
pantothenate, 1 mg L−1; p-aminobenzoic acid, 0.05 mg L−1;
biotin, 0.05 mg L−1; ascorbic acid, 1 mg L−1; adenine sulfate,
20 mg L−1; xanthine, 40 mg L−1; vitamin B12, 0.7 mg L−1;
folate, 0.5 mg L−1; sterilized by filtration); (C) 1.25 × basal
solution (DifcoTM Casamino Acids, vitamin assay BD, Franklin
Lakes, NJ, United States), 10 g L−1; sodium acetate, 10 g
L−1; (NH4)2SO4, 5 g L−1; urea, 2 g L−1; MgSO4·7 H2O,
0.2 g L−1; FeSO4·7 H2O, 0.01 g L−1; MnSO4·7 H2O, 0.007 g
L−1; NaCl, 0.01 g L−1; Tween 80, 1 g L−1; cysteine, 0.5 g
L−1; autoclaved for 30 min at 110◦C after adjusting the
pH to 7.0. Batch fermentations were carried out in mSM7
supplemented with glucose, lactose, fructo-oligosaccharides
(FOS) [P95, degree of polymerization (DP) 2–8, Beneo-
Orafti, Mannheim, Germany], galacto-oligosaccharides (GOS,
DP 3–9, Vivinal, FrieslandCampina, Amersfoort, Netherlands),
xylooligosaccharides (XOS, DP 2–6, FrieslandCampina), or
inulin (HP, DP > 23, Beneo-Orafti), to achieve the final
concentration of 10 g L−1.
Isolation of Roseoflavin-Resistant
Mutants
The approach taken to isolate roseoflavin resistant mutants
is summarized in Supplementary Figure S1. B. infantis
ATCC 15697 was cultured overnight in 5 mL of mMRSlac
[i.e., modified De Man et al. (1960) and Sharpe medium
made from first principles and supplemented with 1% lactose
instead of glucose]. Cells were collected by centrifugation
(6,000 × g for 10 min), washed twice with 5 mL of sterile
H2O, and resuspended in 10 mL of mSM7lac (1% lactose).
The culture was allowed to grow for 5 h under anaerobic
conditions. Aliquots of 100 µL of cell suspension were spread
onto agar plates of mSM7lac supplemented with 0, 25, or
50 µg mL−1 roseoflavin and incubated anaerobically at
37◦C for 48 h. Following isolation of roseoflavin-resistant
derivatives, the promoter and the 5’-UTR regions of the rib
operon of a number of such derivatives were PCR amplified
(using primers 5’ TTCTCCGATACGGGCGATTG 3’ and
5’ TTCGTGGCATCGACCGACAG 3’) and the obtained
products were subjected to Sanger sequencing (Eurofins
Genomics, Germany). The obtained sequences were aligned
using Muscle (Edgar, 2004) and the alignment visualized using
Alignmentviewer4.
Cultivation Conditions
The wild-type (WT) of the type strain B. infantis ATCC 15697
and selected roseoflavin-resistant derivatives were subcultured in
mSM7 supplemented with glucose (mSM7glucose) and were then
incubated anaerobically at 37◦C for 48 h. Growth and production
of intracellular and extracellular riboflavin were assayed in liquid
cultures of mSM7 supplemented with glucose, lactose, FOS, GOS,
XOS, or inulin. Cultures were propagated three times in the
same medium before measuring riboflavin concentration in the
supernatants or in the cell extracts. Growth was determined by
measuring the final optical density at 600 nm (OD600).
Controlled-pH batch cultivation was carried out in triplicate
in laboratory-scale bioreactors (500 mL Mini Bio, Applikon
Biotechnology, Delft, the Netherlands) containing 0.3 L of mSM7
supplemented with lactose (mSM7lac). Bioreactor was inoculated
(10% v/v) with exponential phase pre-cultures grown in the same
medium. The culture was kept at 37◦C under CO2 atmosphere
and stirred at 250 rpm. The pH was continuously measured
(Mettler Toledo InPro 3030/325) and kept at 5.5, the optimal
pH value for bifidobacteria (Amaretti et al., 2007), by automatic
titration with 1 M NaOH. Samples were periodically collected for
analysis of carbohydrates, fermentation products, and growth.
Carbohydrates and fermentation products were analyzed in
the supernatants using an HPLC apparatus with refractive
index detector (1200 System, Agilent Technologies, Waldbronn,
Germany). Elution was carried out with 0.6 mL/min of 0.005 M
H2SO4 through an ion exclusion column (Aminex HPX-87
H, Bio-Rad Laboratories, Inc., Hercules, CA, United States)
maintained at 60◦C.
Riboflavin Assay
Riboflavin concentration was assayed in cell extracts and culture
supernatants. 50 mL of the culture was centrifuged at 9.000 × g
for 10 min at 4◦C. The supernatant was filtered through a
0.22 µm filter and frozen at -20◦C. The biomass was washed
with the same volume of 0.1 M Na-phosphate buffer pH 7.0. The
pellet was resuspended in the buffer (1/10 of the initial volume
of the culture), and the suspension was frozen at -20◦C. The
thawed biomass was passed through the One Shot Cell Disrupter
(Constant Systems, Ltd., Daventry, United Kingdom) at 40 KPsi.
The cell extract, obtained by centrifugation of the sample at
13.000× g, 15 min, 4◦C was maintained at -20◦C.
Riboflavin concentration was quantified using a
microbiological bioassay with Lactobacillus casei subsp.
rhamnosus ATCC 7469 as test organism, based on Woodson
et al. (1946). Growth of the test organism was measured in
5 mL of Riboflavin Assay Medium (BD, Flanklin Lakes, NJ,
United States) supplemented with 5 mL of properly diluted
sample and compared with a calibration curve in the range of
0–300 ng mL−1, according to the protocol described by the
medium manufacturer. Microbiological assay measurements
were replicated at least six times.
4https://alignmentviewer.org
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Real-Time Quantitative qRT-PCR
Differential expression of rib genes was confirmed by real-
time quantitative RT-PCR (qRT-PCR). B. longum subsp. infantis
ATCC 15697 (WT) and its spontaneous mutant ROS25 were
grown in mSM7lac supplemented or not with 20 ng mL−1
riboflavin until mid-exponential growth phase (OD600nm 0.45–
0.7). Cells were harvested by centrifugation at 6.000 × g for
10 min at 4◦C and the pellet was immediately frozen at -
80◦C. For RNA isolation, cells were resuspended in 0.5 mL
of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0),
transferred to a 2 mL screw cap tube. 0.5 g of glass beads
(∼100 µm in diameter), 50 µL of 10 % sodium dodecyl
sulfate (SDS; Sigma-Aldrich, Saint Louis, MO, United States),
and 500 µL of premixed phenol:chloroform:isoamyl alcohol
(25:24:1) were added to the thawed cells in the screw cap
tube. Cells were disrupted using three cycles of 60 s of bead-
beating with a 1 min interval on ice. The cell lysate was
cleared by 10 min centrifugation at 10.000 × g, at 4◦C. The
upper phase was extracted with 500 µL of chloroform:isoamyl
alcohol (24:1). The two phases were separated by centrifugation
(10 min, 10.000 × g, 4◦C) and total RNA was isolated from
the aqueous phase using the High Pure RNA Isolation Kit
(Roche Molecular Systems, Inc., Pleasanton, CA, United States),
according to the manufacturer’s instructions. Total RNA was
treated with DNase I RNAse-free (Roche Molecular Systems,
Inc.) according to manufacturer’s instructions. cDNA synthesis
was performed using total RNA as a template and Transcriptor
Reverse Transcription Kit (Roche Molecular Systems, Inc.)
according to manufacturer’s instructions. qRT-PCR experiments
were carried out using SYBR Green MasterMix (Thermo Fisher
Scientific, Waltham, MA, United States) using cDNA samples
as a template. Primers to amplify ribD and two housekeeping
genes were designed using the Universal ProbeLibrary Assay
Design Center (Roche Molecular Systems, Inc.). The groEL
and gyrA genes were used as housekeeping genes with a
presumed constitutive level of transcription to correct for
variability in the initial amount of total RNA. All qRT-PCRs
were performed in triplicate by means of a LightCycler 480
system (Roche Molecular Systems, Inc.) instrument using 384-
well plates. Thermal cycling conditions were as recommended
by the manufacturer (Roche Molecular Systems, Inc.). The
2−11CT method was used to calculate relative changes in
gene transcription determined from qRT-PCR experiments.
Relative transcription levels of targeted genes from WT
and ROS25 were compared using the Student’s t-test and
were considered significantly upregulated when a p-value of
< 0.05 was obtained.
RNA Isolation and Sequencing
B. longum subsp. infantis ATCC 15697 (WT) and its spontaneous
mutant ROS25 were grown in mSM7lac until mid-exponential
growth phase (OD600nm of 0.7, to obtain a sufficient RNA
yield) for RNA-seq experiments performed in duplicate. Cells
were then harvested by centrifugation and the obtained
pellets were frozen and stored at -80◦C. For RNA extraction,
total RNA of each of the cultures was mixed with 800 µl
of QIAzoL Lysis Reagent (Qiagen, Venlo, Netherlands) in
a sterile tube containing glass beads (Merck, Darmstadt,
Germany). Cells were lysed by alternating 2 min of stirring
the Precellys 24 homogenizer (Bertin instruments, Montigny-
le-Bretonneux, France) with 2 min of static cooling; this
step was repeated three times. The sample was centrifuged
at 12,000 × g for 15 min and the upper phase was
recovered. The RNA was purified using the RNAesy Mini
Kit (Qiagen), following the manufacturer’s protocol. RNA
concentration and purity were evaluated by a Picodrop
microliter spectrophotometer (Victory Scientific, Cambridge,
United Kingdom). Before RNA sequencing, 2.5 µg of total RNA
was treated to remove the ribosomal RNA by the Ribo-Zero
Magnetic Kit (Illumina, Inc., San Diego, CA, United States),
followed by purification of the rRNA-depleted sample by
ethanol precipitation. RNA was processed according to the
manufacturer’s protocol. The yield of rRNA depletion was
confirmed by a Tape station 2200 (Agilent Technologies, Santa
Clara, CA, United States). A whole transcriptome library was
constructed using the TruSeq Stranded RNA LT Kit (Illumina,
Inc.) and samples were loaded into a NextSeq High Output v2
Kit Chemicals 150 cycles (Illumina), according to the technical
support guidelines.
RNA-Seq Analysis
Following sequencing, the reads were depleted of adapters,
quality filtered (with overall quality, quality window and length
filters) and aligned to the B. infantis ATCC 15697 reference
genome (genomic features model GTF file5) through bowtie2
aligner6. The alignment SAM files were further processed using
Samtools to obtain BAM files necessary to obtain matrices
with read counts per gene (normalized by gene length).
Differential gene expression (DGE) analysis was performed
using the R statistical platform and the DESeq2 package
available as part of the Bioconductor release (v.3.9). As a
pre-processing step, rows with zero counts (unmapped genes)
were discarded from the count matrices. Differential expression
analysis was performed on the count matrices using the DESeq
function in DESeq2. Genes with an FDR-adjusted p-value
of < 0.05 and a log2-fold change of > 3 were considered
significantly upregulated.
Determination of β-Galactosidase
Activity and Protein Concentration in the
Supernatant
β-galactosidase activity and total protein concentration were
determined in the supernatant of ROS25 and WT cultures
grown for 6 h in mSM7lac, obtained from three independent
experiments. β-galactosidase activity assay was performed with
o-nitrophenyl-β-D-galactopyranoside (oNPG). The pH of the
supernatant was corrected to 7.0 with a NaOH 3 M solution.
One mL of the sample was incubated at 37◦C for 3 min after
the addition of 0.2 mL of 4 mg mL−1 oNPG. The reaction was
5https://bacteria.ensembl.org
6http://bowtie-bio.sourceforge.net/bowtie2/index.shtml
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stopped by adding 0.5 mL of 1 M Na2CO3. The absorbance of
the sample was read at 420 nm. One unit of β-galactosidase was
defined as the amount of enzyme required to release 1 µmol of
nitrophenol per minute under the assay conditions. The activity
was normalized to the OD600 units of the culture.
To quantify protein levels in the supernatant, the culture
was centrifuged at 9,000 × g for 10 min at 4◦C. The volume
of supernatant corresponding to two units of OD600 of the
culture was transferred to a 2 mL tube and was mixed with
the same volume of 20% (w/v) trichloroacetic acid. The sample
was vortexed, incubated for 1 h in ice, then centrifuged at
13,000 × g for 10 min at 0◦C. The pellet was washed with
300 µl cold acetone. After gently mixing of the suspension
by inversion, the sample was centrifuged at 13,000 × g for
10 min at 0◦C, and the pellet was allowed to dry for 30 min
at room temperature. The sample was resuspended in 20 µl of
Laemmli Loading buffer (Bio-Rad Laboratories, Inc., Hercules,
CA, United States) and supplemented of 2 µl NaOH 1 M.
Proteins were separated by SDS-PAGE using a 5% stacking
and 10% resolving gels. Coomassie brilliant blue-stained gels
were scanned in transmissive mode using a white light source
with the GS-800 Calibrated Densitometer (Bio-Rad Laboratories,
Inc.). Taking into account that the proteins of each run derived
from the same amount of biomass, the total protein levels of
the supernatants were presented as percentage of the highest
value obtained in the data set. In the permeability assays,
means of WT and ROS25 were compared with Student’s t-test
and were considered significantly different when a p-value of
< 0.05 was obtained.
Fecal Cultures
Fresh fecal samples were obtained from 10 healthy volunteers
(five men and five women, aged 25–50 years), who had provided
written informed consent according to the experimental protocol
with ref. no. 968/2019/SPER/UNIMO-RIBOBIF and approved
by the local research ethics committee (Comitato Etico dell’Area
Vasta Emilia Nord, Italy). Feces were homogenized with 3 mm
sterile borosilicate glass beads in mSM7 medium supplemented
with 10 % GOS (mSM7GOS), in an anaerobic cabinet (Concept
Plus, Ruskinn Technology, Ltd., Bridgend, United Kingdom),
under an 85% N2, 10% CO2, and 5% H2 atmosphere. Analysis
of riboflavin content in feces was carried out on dilutions of the
fresh 10 % slurry.
Two sets of fermentation experiments were run in parallel:
(A) fecal cultures inoculated with the fecal slurry pasteurized
for 10 min at 80◦C; (B) fecal cultures inoculated with a viable
microbiota. Fifty mL of mSM7GOS were supplemented with
5 mL of 10% fecal slurry (pasteurized or not) and with 2.5 mL of
ROS25 or WT suspension (2.5 mL of mSM7GOS in the control).
The inocula of ROS25 and WT were prepared by centrifuging
a 24 h culture in mSM7GOS at 6,000 × g for 10 min at 4◦C,
and resuspending the pellet in 1/10 of the volume of the same
medium. Riboflavin content was analyzed after inoculation, and
after 16 and 24 h of incubation at 37◦C in anaerobic conditions.
Two-way analysis of variance (ANOVA), followed by Tukey’s
post hoc test, was used to evaluate differences between carbon
sources and strains (WT and ROS25) in pure culture experiments
and between time points and groups (control, WT, an ROS25)
in fecal cultures. Differences were considered significant when a
p-value of < 0.05 was obtained.
RESULTS
Identification of Riboflavin Biosynthesis
Genes in Bifidobacterium Genomes
The riboflavin and FMN/FAD biosynthetic pathway was
reconstructed in annotated Bifidobacterium genomes available
in the Kyoto Encyclopedia of Genes and Genomes (KEGG)
database. All genes necessary for de novo riboflavin biosynthesis
were found in the genome of B. infantis ATCC 15697 (Figure 1B),
as previously reported by Kwak et al. (2016). The set of
genes includes a complete rib operon (ribD, ribE, ribAB, and
ribH homologues, corresponding to locus tags Blon_0386 to
Blon_0389) encoding the enzymes for riboflavin biosynthesis
from GTP and ribulose-5-phosphate, and an unconnected
ribCF (Blon_2195) homologue encoding a bifunctional riboflavin
kinase/FMN adenylyltransferase, responsible for the conversion
of riboflavin into FMN and FAD (Figures 1A,B). The genome
also harbors a ribU homologue (Blon_0723), predicted to encode
a transporter for the uptake of pre-formed riboflavin located at a
genomic position that is unconnected to that of the rib operon or
ribCF (Figure 1B).
The protein sequences deduced from the rib genes of
B. infantis ATCC 15697 were utilized as query in a search
aimed at identifying homologues in an ORF dataset that
was extracted from 662 genomes, being representative of 83
bifidobacterial (sub)species. Our combined BLASTP and MCL
clustering analysis revealed that de novo riboflavin biosynthesis
appears to be a rather uncommon feature among members of
the genus Bifidobacterium, since homologues of the complete
rib operon were identified in just 16 out of 83 bifidobacterial
species, most of which (14 out of 16) had been isolated from
primates (Figure 2A). In contrast, homologues of ribCF and
ribU are conserved across all members of the genus, occurring
as single copy genes in all investigated species (Figure 2A).
This indicates a general ability of bifidobacteria to rely on
the provision of pre-formed, extracellular vitamin B2 to ensure
a constant FAD/FMN supply. Notably, homologues of the
ribCF and ribU genes from B. infantis have been identified
as essential genes in Bifidobacterium breve UCC2003 using a
combination of Tn5 transposon library and TraDIS sequencing
(Ruiz et al., 2017), supporting their crucial involvement in
specific housekeeping functions in the Bifidobacterium genus.
Inspection of the phylogenetic trend of the two housekeeping
genes rpoB and groEL, and that of the riboflavin-associated genes
ribCF and ribU substantiated that the latter had followed the
same evolutionary course of other housekeeping functions of
this genus, indicating that the uptake and utilization/conversion
of riboflavin represents a core feature of Bifidobacterium that
had already been incorporated in the genomes of its ancestors
(Figure 2B). In support of this notion, homologues of the ribCF
gene harbored by bifidobacterial species isolated from insects
presented the lowest similarity compared to species from other
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FIGURE 2 | Comparative analysis of riboflavin biosynthesis in Bifidobacterium. (A) Comparative heatmap representing the distribution of riboflavin-associated genes
from Bifidobacterium infantis ATCC 15697 across the Bifidobacterium genus. Color gradients indicate the percentage of identity in BLASTP alignments of open
reading frames (ORFs) derived from bifidobacterial genomes grouped by origin of isolation; (B) Entanglement trees obtained from the concatenation of rpoB, groEL
vs. ribU, ribCF genes across the genus Bifidobacterium. The two Neighbor Joining (NJ) trees were built using the MEGA package (statistical validation of 100
bootstrap replicates) and visualized using the “Dendextend” package in R v3.6.2. Connecting lines are color coded based on the presence (red) or absence (blue) of
a rib cluster. The outgroup is indicated in green. (C) Sequence alignment of FMN region in B. infantis and 13 bifidobacterial strains containing a complete rib cluster.
Sequence conservation is indicated with a logo for the consensus. Colored asterisks indicate mutations in FMN riboswitch region upstream of the rib cluster
identified in ROS-resistant isolates. Prediction of the FMN folding was based on Rfam aligment (bases color-coded based on sequence conservation to the Rfam
model RF00050) and was predicted by Rnafold. The obtained structures were obtained using the Infernal and Rnafold predictions in https://structrnafinder.
integrativebioinformatics.me/ (Arias-Carrasco et al., 2018).
ecological niches (40–50% of identity across 70% of sequence
length; Figure 2A). As bifidobacterial isolates from insects have
been identified as being most related to the ancestor of the genus
Bifidobacterium (Milani et al., 2014), the ability to synthesize
riboflavin seems a genetic feature that was not originally present
in this genus. Instead, this property must have been more recently
acquired by certain bifidobacterial species, likely in an ecological
context of riboflavin deficiency.
A PSI-BLAST analysis against the nr database was performed
using the amino acid sequence of the riboflavin synthase (RibE)
as a query. Approximately 90 different taxa encoding RibE
above 50% identity (across 100% of sequence length) were
identified. Phylogenetic inference revealed that the rib clusters
found in the 15 non-human associated bifidobacteria (Figure 2A)
are related and form a separate clade when compared to the
rib cluster present in B. infantis (Supplementary Figure S2).
Phylogenetic relationship analysis suggests that B. infantis
acquired and retained, or lost the primate-associated rib cluster
and then reacquired a rib cluster via a separate horizontal
transfer event (Supplementary Figure S2), perhaps facilitated by
another intestinal bacterium, which could have been either a gut
commensal or pathogen such as Streptococcus or Clostridium.
In order to verify our findings and test the functionality of the
rib cluster we focused on the human-gut commensal B. longum
subsp. infantis ATCC 15697, which was predicted to encode the
complete de novo riboflavin biosynthesis pathway.
FMN Riboswitch Comparison Across
Bifidobacterium
To investigate the presence and sequence conservation of the
FMN riboswitch, a sequence of 500 bp in the 5’-UTR upstream
of ribD was extracted from the Bifidobacterium spp. genomes
bearing the complete rib operon. The structural elements
responsible for the presumed FMN riboswitch, comprised of
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the antiterminator (AntiT, 5’ -TTCAGGGC-3’) which promotes
rib transcription and two anti-antiterminators (Anti-antiT: 5’-
CATCTTC-3’ and 5’-GAAGATG-3’) which pair in the presence
of FMN/FAD and cause premature transcriptional termination
(Winkler et al., 2002), were detected in all 5’-UTRs. Aligning
the FMN riboswitch sequences of various bifidobacteria revealed
that Anti-T and Anti-antiT are located in a conserved region
(Figure 2C), suggesting that the FMN riboswitch is functional
and regulates rib operon transcription. An FMN riboswitch was
also identified in the 5’-untranslated region (5’-UTR) of the ribU
uptake system, indicating that riboflavin synthesis and uptake are
both controlled by the level of flavin cofactors and vitamin in
the environment.
Riboflavin Production in B. longum subsp. infantis
ATCC 15697 and Characterization of
Roseoflavin-Resistant Mutants
To verify the predicted ability of B. infantis ATCC 15697 to
produce riboflavin, it was cultured in a semi-synthetic medium
lacking riboflavin (mSM7lac), allowing growth only if the de novo
biosynthetic pathway for this vitamin was functional. The strain
grew abundantly (final OD600nm = 3.0) and produced the vitamin,
albeit at a low level (less than 0.2 ng mL−1 in a cell extract after
48 h of incubation), without any detectable release of riboflavin
in the medium.
To obtain spontaneous mutants with improved riboflavin
production, B. infantis ATCC 15697 was exposed to 25 and
50 µg mL−1 roseoflavin on mSM7lac plates. Roseoflavin-
resistant colonies were obtained at a similar mutational frequency
(3.4 × 10−7) with either of the two concentrations of this
antimetabolite. A selection of seven roseoflavin-resistant isolates,
hereinafter identified with a ROS designation (Table 1), was
assayed for vitamin B2 production. All ROS mutants exhibited an
increased riboflavin production level of at least one magnitude
when compared with the WT. The concentration of vitamin
released in the supernatant by the mutants ranged from 2.5 to
35 ng mL−1 (Table 1).
The promoter and the 5’UTR regions of the rib operons of
the seven assessed ROS mutants were sequenced, to identify
the mutations likely responsible for the increase in riboflavin
production. The mutants all harbored single point mutations at
TABLE 1 | Mutations identified in flavin mononucleotide (FMN) riboswitch of
roseoflavin-resistant mutants and extracellular riboflavin.








ROS20 6 C T 18
ROS21 41 C T 2.5
ROS22 31 G A 6.5
ROS23 102 G A 16
ROS25 105 G A 35
ROS26 81 G A 4.5
ROS29 64 G A 8
WT – – – < 0.2
Average values are shown (n = 3).
distinct positions of the putative FMN riboswitch (Figure 2C
and Table 1). The identified point mutations were either G →
A or C → T transitions. Three mutants acquired mutations
in one of the two anti-antiterminator regions (Figure 2C and
Table 1). The highest riboflavin production was observed in
mutant ROS25, which was shown to carry a G → A transition
in the anti-antiterminator region of the riboswitch (Table 1).
Riboswitch Disruption and Global Gene
Expression Changes in Spontaneous
Mutant ROS25
In order to assess the effect of the point mutation in the
FMN riboswitch region of ROS25, the transcription level of
ribD (i.e., the first gene of the rib operon) was compared
between the WT and strain ROS25 during the mid-exponential
growth phase in mSM7lac (Figure 3). When riboflavin was
not available in the medium, transcription of ribD was 15-fold
higher in ROS25 than in WT (p-value < 0.05). Addition of
20 ng mL−1 riboflavin to the culture resulted in reduced ribD
transcription in WT (p-value < 0.05), but did not exert a feedback
repressive effect in ROS25, where the response of the riboswitch
was lost and the rib operon was shown to be constitutively
expressed.
To assess the global transcriptional effect of the mutation in
the riboswitch that caused riboflavin overproduction in ROS25,
an RNA-seq experiment was performed on WT and ROS25
cultures growing in mSM7lac without riboflavin supplementation
(Supplementary Table S1). The genes of the rib cluster were
the most differentially expressed between WT and ROS25.
Transcription levels of this cluster in ROS25 were 18-fold
FIGURE 3 | Roseoflavin-resistant isolates. Relative expression of ribD in
wild-type (WT) and ROS25 cells grown to the mid-exponential growth phase
in mSM7lac with 0 or 20 ng mL−1 riboflavin measured by qRT-PCR. *indicate
statistically significant differences between ROS25 and WT samples (p-value
< 0.05).
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higher than its counterpart in WT. Furthermore, various ABC
transporters and sugar permeases were highly expressed in
ROS25, suggesting a more active sugar metabolism in the mutant
than in WT. Genes encoding glycosyltransferases involved in cell
wall metabolism and extracellular polysaccharide biosynthesis
were also upregulated in ROS25 (Supplementary Table S1).
Besides the point mutation in the FMN riboswitch, additional
genetic changes may be present in the genome of ROS25, which
may explain the above transcriptional differences. Transcription
of ribC was similar in both strains, while the genes encoding
FAD-dependent proteins appear to be downregulated in ROS25
(p-value < 0.05; Supplementary Table S1).
Effect of Carbon Sources on Riboflavin
Production
To assess the effect of different carbon sources on riboflavin
production, the intracellular and extracellular production of the
vitamin was determined in batch cultures of WT and ROS25
grown in mSM7 containing glucose, lactose, raffinose, GOS, XOS,
FOS or inulin as the sole carbon source. Both WT and ROS25
grew well with all the carbon sources except XOS (Figure 4).
The growth yield was similar with glucose, lactose, raffinose,
FOS, and GOS (P > 0.05), but lower with inulin (p-value
< 0.05). Notably, the lowest biomass yield was obtained on
inulin, presumably due to the presence of long chains that are not
FIGURE 4 | Growth yield (OD600nm) and riboflavin production in batch cultures of ROS25 and wild-type (WT) grown in mSM7 media containing varying carbohydrate
sources (1%). (A) OD600nm; (B) intracellular riboflavin ng mL−1 of culture; (C) extracellular riboflavin ng mL−1 of supernatant. Values are means ± SD, n = 3. *
indicates statistically significant differences between ROS25 and WT samples (P < 0.05); lowercase letters indicate statistical significant differences for the same
strains on the diverse carbon sources between (p-value < 0.05).
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metabolized by B. longum subsp. infantis, as reported previously
(Kim et al., 2013).
Except for XOS, where poor growth resulted in negligible
amounts of vitamin B2 production, the carbon source did not
affect the concentration of riboflavin accumulated within the
cells or released in the supernatant by both WT and ROS25
cultures (p-value > 0.05). WT and ROS25 presented a similar
concentration of intracellular riboflavin regardless of the carbon
source (p-value > 0.05). In contrast, the difference between WT
and ROS25 was significant with respect to the concentration
of vitamin released in the medium (p-value < 0.05). The
supernatants obtained from WT cultures typically contained
< 0.2 ng mL−1 riboflavin, while those corresponding to ROS25
reached up to 60.8 ng mL−1 for a culture grown on FOS as the
carbon source.
Riboflavin Production and Release by
ROS25
The kinetics of growth and associated riboflavin production was
studied during pH-controlled batch fermentations of ROS25 in
mSM7lac (Figure 5). Following a short lag phase, the culture
rapidly grew and entered the stationary phase after 15 h, when
lactose and the monosaccharides generated by its hydrolysis got
exhausted. Accumulation of acetic and lactic acids originating
from carbohydrate fermentation was observed concomitant with
growth (Figure 5), while riboflavin was released in the medium
throughout growth as well, reaching the highest concentration
(65.3 µg L−1) when the culture entered into the stationary phase,
then slightly declined. The highest rate of vitamin production
(13.9 ng mL−1 h−1) was observed after 6 h of growth when the
specific growth rate was also at its highest level (0.31 h−1).
The extracellular concentrations of riboflavin, β-galactosidase,
and total protein content were compared with those obtained
for WT in order to assess if riboflavin was released in
the supernatant by ROS25 due to cell lysis. After 6 h
of growth in mSM7lac, WT and ROS25 cultures presented
the same turbidity, but the latter had a significantly higher
level of extracellular riboflavin, β-galactosidase, and total
protein content (Figure 6). These data indicate higher cell
wall permeability or partial lysis of ROS25 compared to a
similarly grown WT.
FIGURE 5 | Controlled pH batch fermentation of ROS25 in mSM7lac. (A) Time course of biomass (gray) and riboflavin production (intracellular, fuchsia; extracellular,
purple). (B) Time course of sugars (lactose, green; galactose, light blue; glucose, blue) and fermentation products (acetic acid, orange; lactic acid, green). The figure
represents one representative experiment of the triplicate.
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FIGURE 6 | Permeability of wild-type (WT) and ROS25 cultures grown for 6 h in mSM7lac. Dosage of (A) extracellular riboflavin; (B) β-galactosidase, (C) proteins in
the supernatant. Values are means ± SD, n = 3. * indicates statistically significant differences between ROS25 and WT samples (p-value < 0.05).
Production of Riboflavin in Fecal
Cultures Supplemented With WT and
ROS25
To assess whether consumption of ROS25 as probiotic would
result in in situ riboflavin production which could benefit the
host, the mutant was employed in fecal fermentations. Fresh
feces of 10 healthy adults presented a riboflavin concentration
ranging between 80.7 and 728.2 ng g−1, with a mean
of 298.4 and a median of 251.5 ng g−1 (Supplementary
Figure S3). The six samples with the lowest concentration were
selected to prepare fecal cultures and inoculated (1:100 w/v)
in mSM7GOS medium. Changes in riboflavin concentration
were determined following inoculation with 106 cfu mL−1 of
ROS25, when compared to inoculation of the same level of
WT and to control cultures that were not supplemented with
bifidobacteria. To discriminate between riboflavin originating
from the bifidobacterial supplement and that from other
fecal bacteria, a parallel set of fermentations was carried
out, where the fecal inoculum was heat treated prior to
bifidobacterial inoculation.
With each fecal sample, heat treatment of feces and
subsequent supplementation with ROS25 yielded the biggest
change in riboflavin concentration after 16 or 24 h of incubation
(Figure 7B), with a mean value of 61.2 ng mL−1. Under the
same conditions, the cultures inoculated with WT yielded a
mean of 7.9 ng mL−1, significantly lower than ROS25 and
similar to the control.
All cultures inoculated with viable fecal bacteria accumulated
riboflavin during the first 16 h of the process (p-value < 0.05),
irrespective of bifidobacterial supplementation. This indicated
that other members of microbiota are producing riboflavin
as well. Following 16 and 24 h of incubation, riboflavin
concentration was the highest in the cultures supplemented with
ROS25 and the lowest in those supplemented with WT (p-value
< 0.05). Nonetheless, values were widely dispersed within groups,
thus the difference between ROS25, WT and the control groups
was not significant.
DISCUSSION
Bifidobacteria are widely used as probiotics for their recognized
health benefits and the ability to synthesize important
biomolecules, e.g., vitamins, exopolysaccharides, short-chain
fatty acids, etc. (Bottacini et al., 2017). The de novo synthesis
of riboflavin represents a relatively uncommon feature in
bifidobacterial genomes, being mainly found in representative
species isolated from primates and just in one human gut
commensal, B. infantis. Presumably, riboflavin synthesis is not
crucial for survival of auxotrophic bifidobacterial species as
other members of gut microbiota release this vitamin (Sharma
et al., 2019). Even if the host diet does not supply a sufficient
amount of riboflavin for every member of the gut microbiome,
vitamin sharing allows successful colonization of the gut
by bifidobacteria. For this reason, riboflavin overproducers
holding probiotic attributes could be potential candidates for
in situ production of the vitamin, once these strains reach the
host intestine (Arena et al., 2014). Considering the extensive
application of bifidobacteria in the food and pharmaceutical
fields, coupled with consumer demand for healthier foods, the
use of food-grade microorganisms as in situ vitamin delivery
systems represents an attractive alternative to food fortification
(LeBlanc et al., 2013, 2020; Steinert et al., 2016).
In the current study we performed an extensive comparative
genome analysis of members of the genus Bifidobacterium,
which allowed the identification of the genes required for
uptake and metabolism of riboflavin (ribU and ribCF), both
of which represent housekeeping and essential gene functions.
A de novo biosynthetic pathway of this vitamin was previously
predicted to be present in B. infantis, however, our comparative
study identified for the first time a complete rib cluster
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FIGURE 7 | Extracellular riboflavin in fecal cultures. Riboflavin concentration was determined in the supernatant of fecal cultures at 0, 16, and 24 h of incubation in
the absence of supplements (C) and in presence of riboflavin producing bifidobacteria [wild-type (WT) and ROS25]. (A) Fecal cultures with alive microbiota; (B) fecal
cultures with pasteurized gut microbiota. Lower letters indicate statistically significant differences at the same time point among C, WT, and ROS25 cultures (p-value
< 0.05); upper case letters indicate statistically significant differences for the same culture at various time points (p-value < 0.05).
(ribDEABH) in several bifidobacterial representative taxa, among
which B. infantis is the only human commensal, thus making
this species particularly relevant for the development of
probiotic riboflavin overproducers. Our comparative genomics
and phylogenomic analysis suggests that the acquisition of the
rib cluster by B. infantis was the result of a horizontal transfer
event, which is different from that observed in other non-
human residential bifidobacteria, and likely originating from
Streptococcus or Clostridium.
It is worth mentioning that B. infantis represents an unusual
bifidobacterial strain with a “selfish” strategy of gut colonization
characterized by efficient consumption of available carbohydrates
(e.g., Human Milk Oligosaccharides structures or HMOs), thus
making the saccharolytic metabolism of this species particularly
demanding in terms of redox cofactors (e.g., FAD). For this
reason, the acquisition of the rib cluster by B. infantis may
have represented an important additional supply of riboflavin
and FAD in support of its metabolism and strategy of gut
colonization. B. infantis was specifically isolated from an infant
gut, thus riboflavin synthesis could be a specific adaptation to the
infant gut or diet (Sela et al., 2008).
The toxic riboflavin analog roseoflavin was used to isolate
spontaneous roseoflavin-resistant mutants that upon further
analysis exhibit riboflavin overexpression. All mutations that
had occurred in the rib operon promoter were mapped in
conserved regions of the predicted FMN riboswitch sequence
located in the promoter region of the riboflavin biosynthesis
cluster. Analysis of the spontaneous mutant ROS25, which
was to shown to exhibit the highest production of riboflavin
among the assessed mutants, indicated that a G→ A transition
in the anti-antiterminator region had caused deregulation
of the FMN riboswitch. As a result of this deregulation,
the riboflavin biosynthesis became constitutive in B. infantis
ROS25, with an excess of this vitamin diffusing into the
growth medium. Curiously, no deletions or insertions were
found in the FMN riboswitch region, which is in contrast
to observations made for L. lactis and L. plantarum (Burgess
et al., 2004; Ge et al., 2020). Transitions are the most frequent
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type of point mutations occurring in bacteria, being induced
by spontaneous tautomeric shifts (i.e., transient changes to an
alternative form of a nucleobase molecule) which lead to base
mispairing during replication (Griffiths et al., 2000). Apparently,
high riboflavin production does not pose a constricting metabolic
burden on a cell when grown under favorable laboratory
conditions.
Despite the fact that superior analytical methods can be
employed to provide a more reliable riboflavin quantification
(e.g., HPLC and fluorescence; Mohedano et al., 2019), our
screenings based on an established microbiological assay clearly
demonstrate riboflavin overproduction in ROS25 and other
obtained roseoflavin-resistant derivatives when compared to the
WT strain ATCC 15697).
The mechanism by which riboflavin was released by ROS25
remains unclear. Comparison of permeability of exponential-
growth cultures of WT and ROS25 indicated a more permeable
cell envelope in ROS25 when compared to WT that, however,
did not affect biomass yields and robustness of the culture. The
mechanism underlying augmented permeability deserves deeper
investigation, as it was not evident from RNAseq analysis.
Even though fecal cultures are artifacts that do not reflect the
in vivo situation, where many factors affect the balance between
vitamin production and consumption, including absorption by
the host, the vitamin overproducing derivative ROS25 increased
riboflavin level in both pasteurized and unpasteurized fecal
cultures. Thus, this strain deserves to be challenged in a study
in vivo, to find whether it can be successfully utilized as a
probiotic vitamin “factory” improving the vitamin status of the
host. Since no genetic engineering techniques were used to
modify this strain, ROS25 and similar strains could be readily
used to replace the standard probiotic strain in food formulations
and would supply their host with the required vitamin intake.
According to our results, the strain increased riboflavin level in
both pasteurized and unpasteurized fecal cultures. Sharing of
B-group vitamins has been suggested to promote stability in gut
microbial communities (Sharma et al., 2019).
Besides the direct benefit to the host, such riboflavin
production in the gut could help to stabilize bifidobacterial
species that are auxotrophic for this vitamin. In fact, recent
studies have explored the possibility of using vitamins (e.g.,
riboflavin, niacin) as prebiotics in order to stimulate a selected
population of beneficial gut microbiota (Steinert et al., 2016;
Fangmann et al., 2018).
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